Needham & Company LLC Forecasts Strong Price Appreciation for Privia Health Group (NASDAQ:PRVA) Stock

Privia Health Group (NASDAQ:PRVA) had its target price hoisted by investment analysts at Needham & Company LLC from $25.00 to $30.00 in a note issued to investors on Friday,Benzinga reports. The firm currently has a “buy” rating on the stock. Needham & Company LLC’s price target suggests a potential upside of 20.14% from the stock’s previous close.

Other research analysts also recently issued reports about the stock. Barclays boosted their price objective on shares of Privia Health Group from $19.00 to $21.00 and gave the company an “equal weight” rating in a research report on Friday, November 8th. Macquarie began coverage on shares of Privia Health Group in a research report on Monday, December 16th. They set an “outperform” rating and a $25.00 price objective on the stock. Stephens reaffirmed an “overweight” rating and set a $26.00 price objective on shares of Privia Health Group in a research report on Thursday, January 2nd. Truist Financial boosted their price objective on shares of Privia Health Group from $24.00 to $27.00 and gave the company a “buy” rating in a research report on Friday, November 8th. Finally, JMP Securities reaffirmed a “market outperform” rating and set a $26.00 price objective on shares of Privia Health Group in a research report on Friday, February 14th. One research analyst has rated the stock with a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Buy” and a consensus target price of $26.47.

Privia Health Group Price Performance

PRVA stock opened at $24.97 on Friday. Privia Health Group has a 52-week low of $15.92 and a 52-week high of $26.04. The company’s 50 day simple moving average is $22.40 and its 200-day simple moving average is $20.60. The firm has a market capitalization of $3.00 billion, a P/E ratio of 249.72, a P/E/G ratio of 3.47 and a beta of 0.87.

Institutional Trading of Privia Health Group

Several large investors have recently modified their holdings of PRVA. First Horizon Advisors Inc. boosted its holdings in shares of Privia Health Group by 53.8% during the 4th quarter. First Horizon Advisors Inc. now owns 1,807 shares of the company’s stock worth $35,000 after buying an additional 632 shares during the period. EverSource Wealth Advisors LLC boosted its holdings in shares of Privia Health Group by 7,833.3% during the 4th quarter. EverSource Wealth Advisors LLC now owns 2,380 shares of the company’s stock worth $47,000 after buying an additional 2,350 shares during the period. Financial Management Professionals Inc. bought a new stake in shares of Privia Health Group during the 4th quarter worth $51,000. Quarry LP boosted its holdings in shares of Privia Health Group by 344.6% during the 3rd quarter. Quarry LP now owns 3,268 shares of the company’s stock worth $60,000 after buying an additional 2,533 shares during the period. Finally, KBC Group NV boosted its holdings in shares of Privia Health Group by 34.6% during the 3rd quarter. KBC Group NV now owns 3,385 shares of the company’s stock worth $62,000 after buying an additional 871 shares during the period. 94.48% of the stock is owned by institutional investors.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.